XHKG
9616
Market cap169mUSD
Jul 10, Last price
2.07HKD
1D
0.49%
1Q
-13.75%
IPO
-65.90%
Name
Neusoft Education Technology Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Dalian, People's Republic of China, Neutech Group Limited, established in 2000, operates as an investment holding company. The firm, which rebranded from Neusoft Education Technology Co. Limited in January 2025, primarily delivers digital talent education services across the PRC. Its operations are broadly divided into an Education Business segment and a Healthcare and Wellness Business segment. The Education division provides extensive services, encompassing formal higher education via universities that offer bachelor's and junior college degrees, as well as transfer programs, in addition to educational resources, apprenticeship schemes, and lifelong learning opportunities. Concurrently, the Healthcare and Wellness arm focuses on delivering medical and wellness solutions. Beyond these core areas, the company also engages in various other ventures, including publishing, software development, and property management, alongside offering training, medical, healthcare, and hotel services, as well as medical business and hospital management expertise. Neutech also distributes medical devices.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||